Pharmafile Logo
Pharmafocus logo
Advanced Search

Glenmark

Showing 8 posts of 8 posts found.

glenmark

FDA greenlights Glenmark’s generic version of Biogen’s Tecfidera in relapsing multiple sclerosis

October 7, 2020
Research and Development, Sales and Marketing Biogen, Glenmark, generic, multiple sclerosis

Glenmark Pharma will be celebrating after it secured FDA approval in the US to market dimethyl fumarate, a generic version …

News
glenmark

FDA approves Glenmark’s generic version of Novartis’ Exjade tablets for chronic iron overload

January 7, 2020
Manufacturing and Production, Research and Development Glenmark, exjade, generic, pharma

Indian pharma firm Glenmark has announced it has secured approval from the FDA for its oral deferasirox tablets in the …

News

FDA knocks back Glenmark’s allergic rhinitis therapy Ryaltris

June 25, 2019
Manufacturing and Production, Sales and Marketing FDA, Glenmark, Ryaltris, US, allergy, pharma

Stocks in Indian pharmaceutical firm Glenmark were sent plummeting to a six-year low after it was confirmed that the FDA …

News
novartis_window

Glenmark signs deal with Novartis over distribution in Brazil

June 24, 2019
Sales and Marketing Brazil, Glenmark, Latin America, Novartis, distribution, pharma

Indian firm Glenmark Pharmaceuticals has entered into an agreement with Novartis over the distribution of its respiratory products in Brazil. …

News
fdaoutsideweb

FDA approves first generic versions of Lilly’s ADHD drug

May 31, 2017
Research and Development, Sales and Marketing ADHD, Apotex, Aurobindo, FDA, Glenmark, Teva

The FDA has given its approval for the commercialisation of the first-ever generic versions of Eli Lilly’s Strattera (atomoxetine) for …

News

Glenmark greenlighted to market hypertension generic in US

May 30, 2017
Manufacturing and Production, Sales and Marketing FDA, Glenmark, generic, hypertension

Glenmark Pharmaceuticals has revealed it has been awarded final approval by the FDA to market hypertension treatment nebivolol, a generic …

News

Sanofi strikes Crohn’s deal with Glenmark

May 16, 2011
Research and Development Crohn’s disease, Glenmark, Sanofi

Sanofi has signed a deal with Indian drug maker Glenmark Pharmaceuticals to develop a new treatment for Crohn’s Disease. The …

News

Sanofi signs Indian pain drug development deal

May 5, 2010
Research and Development Glenmark, Sanofi-Aventis, chronic pain, pain therapeutics

Sanofi-Aventis has signed an agreement with Indian firm Glenmark Pharmaceuticals to develop novel agents for the treatment of chronic pain. …

News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024